Literature DB >> 7670494

Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours.

E F Schoenmakers1, S Wanschura, R Mols, J Bullerdiek, H Van den Berghe, W J Van de Ven.   

Abstract

We recently showed that the 1.7 megabase multiple aberration region (MAR) on human chromosome 12q15 harbours recurrent breakpoints frequently found in a variety of benign solid tumours. We now report a candidate gene within MAR suspected to be of pathogenetical relevance. Using positional cloning, we have identified the high mobility group protein gene HMGI-C within a 175 kilobase segment of MAR and characterized its genomic organization. By FISH analysis, we show the majority of the breakpoints of eight different benign solid tumour types fall within this gene. By Southern blot and 3'-RACE analysis, we demonstrate consistent rearrangements in HMGI-C and/or expression of altered HMGI-C transcripts. These results suggest a link between a member of the HMG gene family and benign solid tumour development.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7670494     DOI: 10.1038/ng0895-436

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  125 in total

1.  LPP, an actin cytoskeleton protein related to zyxin, harbors a nuclear export signal and transcriptional activation capacity.

Authors:  M M Petit; J Fradelizi; R M Golsteyn; T A Ayoubi; B Menichi; D Louvard; W J Van de Ven; E Friederich
Journal:  Mol Biol Cell       Date:  2000-01       Impact factor: 4.138

2.  Aberrant ALK tyrosine kinase signaling. Different cellular lineages, common oncogenic mechanisms.

Authors:  M Ladanyi
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

3.  Expression of the high-mobility group protein HMGI(Y) in human trophoblast: potential role in trophoblast invasion of maternal tissue.

Authors:  Ana-Maria Bamberger; Antonis Makrigiannakis; Kerstin Röser; Jessica Radde; Tanja Carstens; Aljoscha M Flohr; Christoph M Bamberger; Jörn Bullerdiek; Thomas Löning
Journal:  Virchows Arch       Date:  2003-09-11       Impact factor: 4.064

4.  Analysis of molecular cytogenetic alterations in uterine leiomyosarcoma by array-based comparative genomic hybridization.

Authors:  Mohammad Raish; Mohsin Khurshid; Mushtaq Ahmad Ansari; Pankaj Kumar Chaturvedi; Su-Mi Bae; Jang Heub Kim; Eun Kyung Park; Dong Chun Park; Woong Shick Ahn
Journal:  J Cancer Res Clin Oncol       Date:  2012-03-15       Impact factor: 4.553

5.  Amplified HMGA2 promotes cell growth by regulating Akt pathway in AML.

Authors:  Li Tan; Xiaoping Wei; Lixia Zheng; Jincai Zeng; Haibo Liu; Shaojiang Yang; Huo Tan
Journal:  J Cancer Res Clin Oncol       Date:  2015-08-30       Impact factor: 4.553

6.  Osteopoikilosis, short stature and mental retardation as key features of a new microdeletion syndrome on 12q14.

Authors:  Björn Menten; Karen Buysse; Farah Zahir; Jan Hellemans; Sara J Hamilton; Teresa Costa; Carrie Fagerstrom; George Anadiotis; Daniel Kingsbury; Barbara C McGillivray; Marco A Marra; Jan M Friedman; Frank Speleman; Geert Mortier
Journal:  J Med Genet       Date:  2007-01-12       Impact factor: 6.318

7.  Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product.

Authors:  D Vallone; S Battista; G M Pierantoni; M Fedele; L Casalino; M Santoro; G Viglietto; A Fusco; P Verde
Journal:  EMBO J       Date:  1997-09-01       Impact factor: 11.598

8.  Binding the mammalian high mobility group protein AT-hook 2 to AT-rich deoxyoligonucleotides: enthalpy-entropy compensation.

Authors:  Suzanne Joynt; Victor Morillo; Fenfei Leng
Journal:  Biophys J       Date:  2009-05-20       Impact factor: 4.033

9.  High-mobility group A1 proteins are overexpressed in human leukaemias.

Authors:  Giovanna Maria Pierantoni; Valter Agosti; Monica Fedele; Heather Bond; Irene Caliendo; Gennaro Chiappetta; Francesco Lo Coco; Fabrizio Pane; Maria Caterina Turco; Giovanni Morrone; Salvatore Venuta; Alfredo Fusco
Journal:  Biochem J       Date:  2003-05-15       Impact factor: 3.857

10.  Can HMGI-C be used as an aid with MDM2 and CDK4 to differentiate liposarcoma subtypes from their mimics?

Authors:  Hanan Alshenawy
Journal:  J Cancer Res Clin Oncol       Date:  2013-03-26       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.